drugset / Trial / NCT05140499

Liposomal Bupivacaine vs Continuous Nerve Catheters for Below the Knee Amputations

NCT05140499 ↗

Phase 4 Terminated 11 enrolled Aurora Quaye MaineHealth · collab
RandomizedParallel-groupSingle-blindOther

Summary

Through this pilot prospective trial, we aim to obtain preliminary data investigating the effectiveness of perineural catheters and liposomal bupivacaine, both currently accepted as standard care at Maine Medical Center, for the management of post-limb amputation pain. We will use the data that we collect to inform the design of a larger, appropriately powered study.

Timeline

Start
2022-08-15
Primary completion
2025-11-20
Completion
2025-12-23

Outcome

Outcome not reported

Stopped (Enrollment): “Difficulty with enrollment”

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.5 % Other
Comparator Bupivacaine Other / unclassified 10 ml Other
Comparator Bupivacaine Other / unclassified 13.3 % Other
Comparator Bupivacaine Other / unclassified 30 ml Other

Indications